CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

NCT06861075 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Portal Hypertension Related to Cirrhosis

Interventions

DRUG: Carvedilol

Sponsor

University Hospital, Clermont-Ferrand